close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

35.36 -0.59 (-1.64%)
Delayed Quote Updated: 3:45 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
Topics Economy
News headline image
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Robotics Earnings Week: Momentum vs. Value as Four Automation Names Report ↗
Via Chartmill
News headline image
3 Reasons OMCL is Risky and 1 Stock to Buy Instead
Omnicell has been treading water for the past six months, recording a small loss of 4.6% while holding steady at $32.74. The stock also fell short of the S&P... 
Via StockStory
Topics Artificial Intelligence
Three Earnings Reports Put the Automation Rally to the Test ↗
Via Chartmill
Omnicell (NASDAQ:OMCL) Q2 Earnings Beat Overshadowed by Disappointing Guidance ↗
Via Chartmill
Topics Earnings
Nvidia, Teradyne, and Omnicell Earnings Set to Test Robotics Sector’s Divergent Momentum ↗
Via Chartmill
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
1 Cash-Producing Stock on Our Buy List and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
3 Small-Cap Stocks We Approach with Caution
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Beyond the AI Titans: Niche Automation Plays Show Strong Momentum and Earnings Acceleration ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Omnicell President Sells 6,753 Shares ↗
Nnamdi Njoku's disposal reduced his direct holdings by 4%, with over half tied to tax withholding from RSU vesting. He retains ~161,223 shares worth $5.81 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Q2 Earnings Call Highlights ↗
Omnicell (NASDAQ:OMCL) reported second-quarter 2026 revenue at the high end of its prior outlook and profitability above expectations, while widening its full-year product bookings range to reflect... 
Via MarketBeat
Topics Earnings World Trade
News headline image
Omnicell (OMCL) Stock Trades Down, Here Is Why
What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 9.9% in the afternoon session after the company issued weak guidance for the upc... 
Via StockStory
Topics Artificial Intelligence
News headline image
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.4% year on year to $312.2 million. On th... 
Via StockStory
News headline image
Omnicell Announces Second Quarter 2026 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what investors should know. Omnicell beat an... 
Via StockStory
News headline image
2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
Via StockStory
News headline image
1 Healthcare Stock to Target This Week and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ... 
Via StockStory
News headline image
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
Nnamdi Njoku Appointed President of Omnicell
From Omnicell, Inc.
Via Business Wire
News headline image
3 Small-Cap Stocks We’re Skeptical Of
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology industry, includ... 
Via StockStory
News headline image
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
From Omnicell, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.